Fat part of biotech trade is seen

October 6, 2025 Leave a comment

While specific U.S. biotech’s are held in client portfolios, the broader sector has seen the ‘fat part’ of the trade.

An extreme low in the S&P Biotech ETF (XBI) was mentioned in the April 6, 2025 edition of my Macro Extremes weekly note.

Macro Extremes (week ending April 4, 2025)

and an overbought extreme was highlighted in yesterdays edition.

Macro Extremes (week ending October 3, 2025)

For now, ~37% over 6 months will do.

I’ll leave the next 10% for someone else.

October 6, 2025

rob@karriasset.com.au

Filed under Finance & Investment Tagged with , , , , ,

Dark clouds for biotech

November 19, 2024 Leave a comment

Last week’s abrupt decline in the U.S. #biotech indices look like the beginning of a larger decline.

It could be a dark winter while political machinations sort themselves out.

For some reference, while the iShares Biotech ETF #IBB will likely bounce in the near term, I’ll look for it to eventually trade down slightly below the $100 mark.

November 19, 2024

rob@karriasset.com.au

Screenshot

Filed under Finance & Investment Tagged with , , , , , ,